Facial Injectables Market

Facial Injectables Market (Product Type: Collagen, Hyaluronic Acid, Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), Polymethylmethacrylate Beads (PMMA Microspheres), Poly-L-Lactic Acid (PLLA), and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Global Facial Injectables Market Outlook 2031

  • The global industry was valued at US$ 13.5 Bn in 2022
  • It is projected to advance at a CAGR of 12.0% from 2023 to 2031 and reach US$ 37.1 Bn by the end of 2031

Analysts’ Viewpoint

Increase in non-invasive cosmetic procedures, rise in disposable income, and changing consumer preferences are driving the global facial injectables market. Growing number of individuals are opting for facial injectables to address aesthetic concerns. Hence, demand for dermal fillers and botulinum toxin treatments has increased as people seek to enhance their appearance and combat signs of aging. Aging population and the desire to maintain youthful look are anticipated to bolster market expansion. Furthermore, surge in accessibility and affordability of these treatments, particularly in emerging economies, are likely to propel the global facial injectables market size.

Advancements in technology and product innovation offer lucrative opportunities to market players. Manufacturers are introducing improved facial injectables with enhanced efficacy, safety, and longer lasting effects in order to increase consumer base.

Facial Injectables Market

Global Facial Injectables Market Introduction

Facial injectables encompass dermal fillers and botulinum toxin, which are used to enhance appearance and address aesthetic concerns. Dermal fillers are gel-like substances injected to restore volume, smoothen wrinkles, and improve facial contours.

These are commonly applied to areas such as cheeks, lips, and nasolabial folds. Botulinum toxin, known as Botox, is injected into facial muscles to temporarily relax them, reducing dynamic wrinkles caused by muscle movements. This treatment is effective for frown lines, forehead wrinkles, and crow's feet.

Facial injectables provide a non-invasive solution for achieving a more youthful and rejuvenated look. Dermal fillers typically contain hyaluronic acid, calcium hydroxylapatite, or poly-L-lactic acid, while Botox is a neurotoxic protein. These treatments are performed by qualified professionals and offer temporary results, usually lasting several months to a year.

Increase in Aesthetic Consciousness and Rise in Number of Cosmetic Procedures

Surge in aesthetic consciousness among individuals leading to increased demand for cosmetic procedures is bolstering the global facial injectables market development. The number of people seeking aesthetic enhancements and cosmetic treatments has increased in the past few years. This can be ascribed to factors such as social media influence, changing beauty standards, and desire for self-improvement.

Introduction of cost-effective facial injectables is also fueling market growth. Advancements in technology have allowed for the development of more affordable injectable products without compromising on quality or efficacy. This has made facial injectables more accessible to a broader consumer base, including those who may have been previously deterred by high costs.

According to the International Society of Aesthetic Plastic Surgery (ISAPS) report in 2021, over 10,129,528 cosmetic surgical procedures were performed in 2021, with non-surgical procedures, such as facial injectables, accounting for a significant number. Popular injectables mentioned in the report include calcium hydroxylapatite, poly-L-lactic acid, botulinum toxin, and hyaluronic acid. This data underscores the widespread adoption of facial injectables and their positive impact on the market's growth.

Surge in Preference for Minimally Invasive Treatments

Increase in demand for non-invasive procedures is a significant driver of global facial injectables market demand. Consumers are increasingly opting for cosmetic treatments that provide aesthetic enhancements without the need for invasive surgery. This shift in preference is driven by several factors, including a desire for quicker recovery, minimal downtime, and reduced risks associated with surgical procedures.

Minimally invasive surgeries are rapidly replacing invasive surgeries in the field of aesthetics. Patients are increasingly seeking procedures that offer similar benefits to traditional surgeries but with less invasiveness and associated complications.

The American Society of Plastic Surgeons reported that nearly 18 million aesthetic treatments were performed in the U.S. in 2020. Of these, around 16 million were non-invasive or minimally invasive procedures, highlighting the overwhelming demand for such treatments among patients. This data underscores the increasing adoption of minimally invasive surgeries and the role of facial injectables in meeting this demand.

Adoption of non-invasive procedures is also driven by societal factors. There is a general trend toward seeking natural-looking results and subtle enhancements, which can be achieved effectively through facial injectables. Patients are increasingly prioritizing procedures that maintain their facial expressions and allow for a gradual transformation, rather than drastic changes associated with surgical interventions.

Ability to Smoothen Wrinkles and Enhance Facial Contours Fueling Hyaluronic Acid Segment

In terms of product type, the hyaluronic acid (HA) segment accounted for the largest global facial injectables market share in 2022. Hyaluronic acid is a naturally occurring substance found in the human body and is widely used in the cosmetic industry for facial rejuvenation and volumizing.

Hyaluronic acid-based dermal fillers are popular due to the ability to add volume, smoothen wrinkles, and enhance facial contours. These are commonly used for procedures such as lip augmentation, cheek augmentation, and filling of nasolabial folds.

Demand for hyaluronic acid-based dermal fillers has been consistently high, driven by factors such as increase in geriatric population, rise in consumer focus on appearance, and advancements in aesthetic procedures.

High Demand for Wrinkles & Fine Lines Treatment Bolstering Facial Line Correction Segment

Based on application, the facial line correction segment is likely to dominate the global facial injectables industry during the forecast period. Facial line correction refers to the treatment of wrinkles and fine lines on the face using injectable fillers, primarily hyaluronic acid-based dermal fillers.

The facial line correction segment's dominance can be ascribed to rise in demand for non-surgical cosmetic procedures aimed at reducing visible signs of aging. As individuals seek to maintain a youthful appearance without undergoing invasive surgical procedures, facial line correction with injectable fillers has become an attractive option.

Facial line correction treatment can address a range of concerns, including the treatment of crow's feet, forehead lines, frown lines, and marionette lines. This versatility makes it a popular choice among both younger individuals seeking preventive measures and older individuals looking to reverse the signs of aging.

Highly Skilled and Diverse Medical Workforce Driving Hospitals Segment

In terms of end-user, the hospitals segment is projected to account for leading share of the global facial injectables market during the forecast period.

Hospitals are equipped with advanced medical infrastructure and facilities, allowing them to provide comprehensive and specialized care. These have the necessary resources to perform various cosmetic procedures, including facial injectables, in a safe and controlled environment.

Hospitals typically employ a skilled and diverse medical workforce, including plastic surgeons, dermatologists, and aesthetic specialists. These professionals have the expertise and experience required to administer injectable treatments accurately and ensure optimal patient outcomes.

Hospitals often have access to a range of injectable products, including hyaluronic acid-based fillers, due to their established relationships with pharmaceutical manufacturers and suppliers. This enables hospitals to offer a diverse selection of products to meet the specific needs and preferences of their patients.

Regional Outlook

As per facial injectables market trends, North America accounted for leading market share in 2022. This is ascribed to large population seeking aesthetic enhancements, strong emphasis on youthful appearances, and high disposable income among consumers.

Advancements in injectable techniques, product formulations, and safety measures have contributed to market expansion in North America. The region has a well-established healthcare infrastructure, with a significant presence of specialized clinics, medical spas, and cosmetic surgery centers offering facial injectable treatments.

The market in North America is highly competitive, with leading manufacturers and pharmaceutical companies introducing innovative products to cater to the growing demand.

The facial injectables market in Asia Pacific is experiencing rapid growth driven by factors such as large population, increase in disposable income, growing beauty consciousness, and rise in demand for non-surgical cosmetic procedures. The market in the region is characterized by expanding aesthetic clinics, advancements in technology, and strong presence of key market players.

Analysis of Key Players

Expansion of product portfolio and mergers & acquisitions are key strategies adopted by prominent manufacturers in the market. Allergan, Inc., Ipsen (Mayroy SA), Merz Pharma, Suneva Medical, Inc., Medytox, Inc., Sinclair Pharma, Bloomage BioTechnology, Anika Therapeutics, Inc., Prollenium Medical Technologies, and Galderma are the prominent players in the market.

Key Developments in Global Facial Injectables Market

  • In May 2023, Evolus, a leading company, announced entry into the U.S. dermal filler market with the introduction of Evolysse. This first-generation cold technology hyaluronic acid (HA) product, developed by Symatese, marks a significant expansion for Evolus. Additionally, Evolus has a portfolio of five fillers currently in late-stage development, with the anticipation of the first approval in the first half of 2025.
  • In January 2023, Galderma unveiled a revolutionary solution called FACE by Galderma, aimed at assisting healthcare professionals in expanding their practice and enhancing patient satisfaction. This cutting-edge augmented reality application employs digital facial assessment to simulate the outcomes of injectable treatments in real time. With advanced wrinkle detection and dynamic "before and after" images showcasing 19 different injectable treatments, the application offers a comprehensive approach to personalized care.
  • In May 2021, AbbVie's subsidiary, Allergan Aesthetics, received FDA approval for SKINVIVE by JUVÉDERM. This groundbreaking product is designed to enhance cheek smoothness in adults aged 21 and above. It is the sole hyaluronic acid (HA) intradermal microdroplet injection available in the U.S., offering long-lasting results for up to six months when used optimally. This development marks a significant advancement in aesthetic treatments, providing individuals with an effective solution for improving the texture of their skin.

The facial injectables market report profiles key players based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Global Facial Injectables Market Snapshot

Attribute Detail

Size in 2022

US 13.5 Bn

Forecast (Value) in 2031

More than US$ 37.1 Bn

Growth Rate (CAGR)

12.0%

Forecast Period

2023-2031

Historical Data Available for

2017-2021

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.

Competition Landscape

  • Market share analysis by company (2021)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Product Type
    • Collagen
    • Hyaluronic Acid (HA)
    • Botulinum Toxin Type A
    • Calcium Hydroxylapatite (CaHA)
    • Polymethylmethacrylate Beads (PMMA Microspheres)
    • Poly-L-Lactic Acid (PLLA)
    • Others (Polyalkylimide)
  • Application
    • Facial Line Correction
    • Lip Augmentation
    • Acne Scar Treatment
    • Face Lift
    • Lipoatrophy Treatment
    • Others (earlobe rejuvenation)
  • End-user
    • Hospitals
    • Dermatology Clinics
    • Others (beauty clinics)

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Allergan, Inc.
  • Ipsen (Mayroy SA)
  • Merz Pharma
  • Suneva Medical, Inc.
  • Medytox, Inc.
  • Sinclair Pharma
  • Bloomage BioTechnology
  • Anika Therapeutics, Inc.
  • Prollenium Medical Technologies
  • Galderma

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global facial injectables market in 2022?

It was valued at US$ 13.5 Bn in 2022.

How big will be the facial injectables industry by 2031?

It is projected to reach more than US$ 37.1 Bn by 2031.

What will be the CAGR of the facial injectables business during the forecast period?

It is anticipated to advance at a CAGR of 12.0% from 2023 to 2031.

Which are the key factors driving demand for facial injectables?

Rise in aesthetic consciousness, surge in number of cosmetic procedures, and increase in preference for minimally invasive treatments.

Which was the leading facial injectables segment?

Hyaluronic acid (HA) was the leading segment, with more than 42% share in 2022.

Which region will account for major share of facial injectables sales during the forecast period?

North America is expected to account for the largest share from 2023 to 2031.

Who are the prominent facial injectables providers?

Allergan, Inc., Ipsen (Mayroy SA), Merz Pharma, Suneva Medical, Inc., Medytox, Inc., Sinclair Pharma, Bloomage BioTechnology, Anika Therapeutics, Inc., Prollenium Medical Technologies and Galderma.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Facial Injectables Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Facial Injectables Market Analysis and Forecast, 2017-2031

            4.4.1. Market Revenue Projections (US$ Mn)

            4.4.2. Market Volume/Unit Shipments Projections

        4.5. Porter’s Five Forces Analysis

    5. Key Insights

        5.1. Technological Advancements

        5.2. Pricing Analysis

        5.3. Key Mergers & Acquisitions

        5.4. Top 3 Players Operating in the Market Space

        5.5. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)

    6. Global Facial Injectables Market Analysis and Forecast, by Product Type

        6.1. Introduction & Definition

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Product Type, 2017-2031

            6.3.1. Collagen

            6.3.2. Hyaluronic Acid (HA)

            6.3.3. Botulinum Toxin Type A

            6.3.4. Calcium Hydroxylapatite (CaHA)

            6.3.5. Polymethylmethacrylate Beads (PMMA Microspheres)

            6.3.6. Poly-L-Lactic Acid (PLLA)

            6.3.7. Others (Polyalkylimide )

        6.4. Market Attractiveness Analysis, by Product Type

    7. Global Facial Injectables Market Analysis and Forecast, by Application

        7.1. Introduction & Definition

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by Application, 2017-2031

            7.3.1. Facial Line Correction

            7.3.2. Lip Augmentation

            7.3.3. Acne Scar Treatment

            7.3.4. Face Lift

            7.3.5. Lipoatrophy Treatment

            7.3.6. Others (earlobe rejuvenation)

        7.4. Market Attractiveness Analysis, by Application

    8. Global Facial Injectables Market Analysis and Forecast, by End-user

        8.1. Introduction & Definition

        8.2. Key Findings/Developments

        8.3. Market Value Forecast, by End-user, 2017-2031

            8.3.1. Hospitals

            8.3.2. Dermatology Clinics

            8.3.3. Others (beauty clinics)

        8.4. Market Attractiveness Analysis, by End-user

    9. Global Facial Injectables Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Market Value Forecast, by Region, 2017-2031

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Market Attractiveness Analysis, by Region

    10. North America Facial Injectables Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast, by Product Type, 2017-2031

            10.2.1. Collagen

            10.2.2. Hyaluronic Acid (HA)

            10.2.3. Botulinum Toxin Type A

            10.2.4. Calcium Hydroxylapatite (CaHA)

            10.2.5. Polymethylmethacrylate Beads (PMMA Microspheres)

            10.2.6. Poly-L-Lactic Acid (PLLA)

            10.2.7. Others (Polyalkylimide)

        10.3. Market Value Forecast, by Application, 2017-2031

            10.3.1. Facial Line Correction

            10.3.2. Lip Augmentation

            10.3.3. Acne Scar Treatment

            10.3.4. Face Lift

            10.3.5. Lipoatrophy Treatment

            10.3.6. Others (earlobe rejuvenation)

        10.4. Market Value Forecast, by End-user, 2017-2031

            10.4.1. Hospitals

            10.4.2. Dermatology Clinics

            10.4.3. Others (Beauty Clinics)

        10.5. Market Value Forecast, by Country, 2017-2031

            10.5.1. U.S.

            10.5.2. Canada

        10.6. Market Attractiveness Analysis

            10.6.1. By Product Type

            10.6.2. By Application

            10.6.3. By End-user

            10.6.4. By Country

    11. Europe Facial Injectables Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Product Type, 2017-2031

            11.2.1. Collagen

            11.2.2. Hyaluronic Acid (HA)

            11.2.3. Botulinum Toxin Type A

            11.2.4. Calcium Hydroxylapatite (CaHA)

            11.2.5. Polymethylmethacrylate Beads (PMMA Microspheres)

            11.2.6. Poly-L-Lactic Acid (PLLA)

            11.2.7. Others (Polyalkylimide)

        11.3. Market Value Forecast, by Application, 2017-2031

            11.3.1. Facial Line Correction

            11.3.2. Lip Augmentation

            11.3.3. Acne Scar Treatment

            11.3.4. Face Lift

            11.3.5. Lipoatrophy Treatment

            11.3.6. Others (earlobe rejuvenation)

        11.4. Market Value Forecast, by End-user, 2017-2031

            11.4.1. Hospitals

            11.4.2. Dermatology Clinics

            11.4.3. Others (beauty clinics)

        11.5. Market Value Forecast, by Country/Sub-region, 2017-2031

            11.5.1. Germany

            11.5.2. U.K.

            11.5.3. France

            11.5.4. Italy

            11.5.5. Spain

            11.5.6. Rest of Europe

        11.6. Market Attractiveness Analysis

            11.6.1. By Product Type

            11.6.2. By Application

            11.6.3. By End-user

            11.6.4. By Country/Sub-region

    12. Asia Pacific Facial Injectables Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Product Type, 2017-2031

            12.2.1. Collagen

            12.2.2. Hyaluronic Acid (HA)

            12.2.3. Botulinum Toxin Type A

            12.2.4. Calcium Hydroxylapatite (CaHA)

            12.2.5. Polymethylmethacrylate Beads (PMMA Microspheres)

            12.2.6. Poly-L-Lactic Acid (PLLA)

            12.2.7. Others (Polyalkylimide)

        12.3. Market Value Forecast, by Application, 2017-2031

            12.3.1. Facial Line Correction

            12.3.2. Lip Augmentation

            12.3.3. Acne Scar Treatment

            12.3.4. Face Lift

            12.3.5. Lipoatrophy Treatment

            12.3.6. Others (earlobe rejuvenation)

        12.4. Market Value Forecast, by End-user, 2017-2031

            12.4.1. Hospitals

            12.4.2. Dermatology Clinics

            12.4.3. Others (beauty clinics)

        12.5. Market Value Forecast, by Country/Sub-region, 2017-2031

            12.5.1. China

            12.5.2. Japan

            12.5.3. India

            12.5.4. Australia & New Zealand

            12.5.5. Rest of Asia Pacific

        12.6. Market Attractiveness Analysis

            12.6.1. By Product Type

            12.6.2. By Application

            12.6.3. By End-user

            12.6.4. By Country/Sub-region

    13. Latin America Facial Injectables Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Product Type, 2017-2031

            13.2.1. Collagen

            13.2.2. Hyaluronic Acid (HA)

            13.2.3. Botulinum Toxin Type A

            13.2.4. Calcium Hydroxylapatite (CaHA)

            13.2.5. Polymethylmethacrylate Beads (PMMA Microspheres)

            13.2.6. Poly-L-Lactic Acid (PLLA)

            13.2.7. Others (Polyalkylimide)

        13.3. Market Value Forecast, by Application, 2017-2031

            13.3.1. Facial Line Correction

            13.3.2. Lip Augmentation

            13.3.3. Acne Scar Treatment

            13.3.4. Face Lift

            13.3.5. Lipoatrophy Treatment

            13.3.6. Others (earlobe rejuvenation)

        13.4. Market Value Forecast, by End-user, 2017-2031

            13.4.1. Hospitals

            13.4.2. Dermatology Clinics

            13.4.3. Others (beauty clinics)

        13.5. Market Value Forecast, by Country/Sub-region, 2017-2031

            13.5.1. Brazil

            13.5.2. Mexico

            13.5.3. Rest of Latin America

        13.6. Market Attractiveness Analysis

            13.6.1. By Product Type

            13.6.2. By Application

            13.6.3. By End-user

            13.6.4. By Country/Sub-region

    14. Middle East & Africa Facial Injectables Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Product Type, 2017-2031

            14.2.1. Collagen

            14.2.2. Hyaluronic Acid (HA)

            14.2.3. Botulinum Toxin Type A

            14.2.4. Calcium Hydroxylapatite (CaHA)

            14.2.5. Polymethylmethacrylate Beads (PMMA Microspheres)

            14.2.6. Poly-L-Lactic Acid (PLLA)

            14.2.7. Others (Polyalkylimide)

        14.3. Market Value Forecast, by Application, 2017-2031

            14.3.1. Facial Line Correction

            14.3.2. Lip Augmentation

            14.3.3. Acne Scar Treatment

            14.3.4. Face Lift

            14.3.5. Lipoatrophy Treatment

            14.3.6. Others (earlobe rejuvenation)

        14.4. Market Value Forecast, by End-user, 2017-2031

            14.4.1. Hospitals

            14.4.2. Dermatology Clinics

            14.4.3. Others (beauty clinics)

        14.5. Market Value Forecast, by Country/Sub-region, 2017-2031

            14.5.1. GCC Countries

            14.5.2. South Africa

            14.5.3. Rest of Middle East & Africa

        14.6. Market Attractiveness Analysis

            14.6.1. By Product Type

            14.6.2. By Application

            14.6.3. By End-user

            14.6.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player - Competition Matrix (by tier and size of companies)

        15.2. Market Share Analysis, by Company (2021)

        15.3. Company Profiles

            15.3.1. Allergan, Inc.

                15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.1.2. Product Portfolio

                15.3.1.3. Financial Overview

                15.3.1.4. SWOT Analysis

                15.3.1.5. Strategic Overview

            15.3.2. Ipsen (Mayroy SA)

                15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.2.2. Product Portfolio

                15.3.2.3. Financial Overview

                15.3.2.4. SWOT Analysis

                15.3.2.5. Strategic Overview

            15.3.3. Merz Pharma

                15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.3.2. Product Portfolio

                15.3.3.3. Financial Overview

                15.3.3.4. SWOT Analysis

                15.3.3.5. Strategic Overview

            15.3.4. Suneva Medical, Inc.

                15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.4.2. Product Portfolio

                15.3.4.3. Financial Overview

                15.3.4.4. SWOT Analysis

                15.3.4.5. Strategic Overview

            15.3.5. Medytox Inc.

                15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.5.2. Product Portfolio

                15.3.5.3. Financial Overview

                15.3.5.4. SWOT Analysis

                15.3.5.5. Strategic Overview

            15.3.6. Sinclair Pharma

                15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.6.2. Product Portfolio

                15.3.6.3. Financial Overview

                15.3.6.4. SWOT Analysis

                15.3.6.5. Strategic Overview

            15.3.7. Bloomage BioTechnology

                15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.7.2. Product Portfolio

                15.3.7.3. Financial Overview

                15.3.7.4. SWOT Analysis

                15.3.7.5. Strategic Overview

            15.3.8. Anika Therapeutics, Inc.

                15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.8.2. Product Portfolio

                15.3.8.3. Financial Overview

                15.3.8.4. SWOT Analysis

                15.3.8.5. Strategic Overview

            15.3.9. Prollenium Medical Technologies

                15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.9.2. Product Portfolio

                15.3.9.3. Financial Overview

                15.3.9.4. SWOT Analysis

            15.3.10. Galderma

                15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.10.2. Product Portfolio

                15.3.10.3. Financial Overview

                15.3.10.4. SWOT Analysis

                15.3.10.5. Strategic Overview

    List of Tables

    Table 01: Global Facial Injectables Market Value (US$ Mn) Forecast, by Product Type, 2017-2031

    Table 02: Global Facial Injectables Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 03: Global Facial Injectables Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    Table 04: Global Facial Injectables Market Value (US$ Mn) Forecast, by Region, 2017-2031

    Table 05: North America Facial Injectables Market Value (US$ Mn) Forecast, by Country, 2017-2031

    Table 06: North America Facial Injectables Market Value (US$ Mn) Forecast, by Product Type, 2017-2031

    Table 07: North America Facial Injectables Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 08: North America Facial Injectables Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    Table 09: Europe Facial Injectables Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 10: Europe Facial Injectables Market Value (US$ Mn) Forecast, by Product Type, 2017-2031

    Table 11: Europe Facial Injectables Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 12: Europe Facial Injectables Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    Table 13: Asia Pacific Facial Injectables Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 14: Asia Pacific Facial Injectables Market Value (US$ Mn) Forecast, by Product Type, 2017-2031

    Table 15: Asia Pacific Facial Injectables Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 16: Asia Pacific Facial Injectables Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    Table 17: Latin America Facial Injectables Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 18: Latin America Facial Injectables Market Value (US$ Mn) Forecast, by Product Type, 2017-2031

    Table 19: Latin America Facial Injectables Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 20: Latin America Facial Injectables Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    Table 21: Middle East & Africa Facial Injectables Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 22: Middle East & Africa Facial Injectables Market Value (US$ Mn) Forecast, by Product Type, 2017-2031

    Table 23: Middle East & Africa Facial Injectables Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 24: Middle East & Africa Facial Injectables Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    List of Figures

    Figure 01: Global Facial Injectables Market Value (US$ Mn) Forecast, 2017-2031

    Figure 02: Global Facial Injectables Market Value Share, by Product Type, 2022

    Figure 03: Global Facial Injectables Market Value Share, by Application, 2022

    Figure 04: Global Facial Injectables Market Value Share, by End-user, 2022

    Figure 05: Global Facial Injectables Market Value Share, by Region, 2022

    Figure 06: Global Facial Injectables Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 07: Global Facial Injectables Market Attractiveness Analysis, by Product Type, 2023-2031

    Figure 08: Global Facial Injectables Market Revenue (US$ Mn), by Collagen, 2017-2031

    Figure 09: Global Facial Injectables Market Revenue (US$ Mn), by Hyaluronic Acid (HA), 2017-2031

    Figure 10: Global Facial Injectables Market Revenue (US$ Mn), by Botulinum Toxin Type A, 2017-2031

    Figure 11: Global Facial Injectables Market Revenue (US$ Mn), by Calcium Hydroxylapatite (CaHA), 2017-2031

    Figure 12: Global Facial Injectables Market Revenue (US$ Mn), by Polymethylmethacrylate Beads (PMMA Microspheres), 2017-2031

    Figure 13: Global Facial Injectables Market Revenue (US$ Mn), by Poly-L-Lactic Acid (PLLA), 2017-2031

    Figure 14: Global Facial Injectables Market Revenue (US$ Mn), by Others (Polyalkylimide), 2017-2031

    Figure 15: Global Facial Injectables Market Value Share Analysis, by Application, 2022 and 2031

    Figure 16: Global Facial Injectables Market Attractiveness Analysis, by Application, 2023-2031

    Figure 17: Global Facial Injectables Market Revenue (US$ Mn), by Facial Line Correction, 2017-2031

    Figure 18: Global Facial Injectables Market Revenue (US$ Mn), by Lip Augmentation, 2017-2031

    Figure 19: Global Facial Injectables Market Revenue (US$ Mn), by Acne Scar Treatment, 2017-2031

    Figure 20: Global Facial Injectables Market Revenue (US$ Mn), by Face Lift, 2017-2031

    Figure 21: Global Facial Injectables Market Revenue (US$ Mn), by Lipoatrophy Treatment, 2017-2031

    Figure 22: Global Facial Injectables Market Revenue (US$ Mn), by Others (earlobe rejuvenation), 2017-2031

    Figure 23: Global Facial Injectables Market Value Share Analysis, by End-user, 2017-2031

    Figure 24: Global Facial Injectables Market Attractiveness Analysis, by End-user, 2023-2031

    Figure 25: Global Facial Injectables Market Revenue (US$ Mn), by Hospitals, 2017-2031

    Figure 26: Global Facial Injectables Market Revenue (US$ Mn), by Dermatology Clinics, 2017-2031

    Figure 27: Global Facial Injectables Market Revenue (US$ Mn), by Others (beauty clinics), 2017-2031

    Figure 28: Global Facial Injectables Market Value Share Analysis, by Region, 2022 and 2031

    Figure 29: Global Facial Injectables Market Attractiveness Analysis, by Region, 2023-2031

    Figure 30: North America Facial Injectables Market Value (US$ Mn) Forecast, 2017-2031

    Figure 31: North America Facial Injectables Market Value Share Analysis, by Country, 2022 and 2031

    Figure 32: North America Facial Injectables Market Attractiveness Analysis, by Country, 2023-2031

    Figure 33: North America Facial Injectables Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 34: North America Facial Injectables Market Attractiveness Analysis, by Product Type, 2023-2031

    Figure 35: North America Facial Injectables Market Value Share Analysis (US$ Mn), by Application, 2017-2031

    Figure 36: North America Facial Injectables Market Attractiveness Analysis, by Application, 2023-2031

    Figure 37: North America Facial Injectables Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 38: North America Facial Injectables Market Attractiveness Analysis, by End-user, 2023-2031

    Figure 39: Europe Facial Injectables Market Value (US$ Mn) Forecast, 2017-2031

    Figure 40: Europe Facial Injectables Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 41: Europe Facial Injectables Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 42: Europe Facial Injectables Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 43: Europe Facial Injectables Market Attractiveness Analysis, by Product Type, 2023-2031

    Figure 44: Europe Facial Injectables Market Value Share Analysis, by Application, 2017-2031

    Figure 45: Europe Facial Injectables Market Attractiveness Analysis, by Application, 2023-2031

    Figure 46: Europe Facial Injectables Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 47: Europe Facial Injectables Market Attractiveness Analysis, by End-user, 2023-2031

    Figure 48: Asia Pacific Facial Injectables Market Value (US$ Mn) Forecast, 2017-2031

    Figure 49: Asia Pacific Facial Injectables Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 50: Asia Pacific Facial Injectables Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 51: Asia Pacific Facial Injectables Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 52: Asia Pacific Facial Injectables Market Attractiveness Analysis, by Product Type, 2023-2031

    Figure 53: Asia Pacific Facial Injectables Market Value Share Analysis, by Application, 2022 and 2031

    Figure 54: Asia Pacific Facial Injectables Market Attractiveness Analysis, by Application, 2023-2031

    Figure 55: Asia Pacific Facial Injectables Market Value Share Analysis, by End-user, 2017-2031

    Figure 56: Asia Pacific Facial Injectables Market Attractiveness Analysis, by End-user, 2023-2031

    Figure 57: Latin America Facial Injectables Market Value (US$ Mn) Forecast, 2017-2031

    Figure 58: Latin America Facial Injectables Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 59: Latin America Facial Injectables Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 60: Latin America Facial Injectables Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 61: Latin America Facial Injectables Market Attractiveness Analysis, by Product Type, 2023-2031

    Figure 62: Latin America Facial Injectables Market Value Share Analysis, by Application, 2022 and 2031

    Figure 63: Latin America Facial Injectables Market Attractiveness Analysis, by Application, 2023-2031

    Figure 64: Latin America Facial Injectables Market Value Share Analysis, by End-user, 2017-2031

    Figure 65: Latin America Facial Injectables Market Attractiveness Analysis, by End-user, 2023-2031

    Figure 66: Middle East & Africa Facial Injectables Market Value (US$ Mn) Forecast, 2017-2031

    Figure 67: Middle East & Africa Facial Injectables Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 68: Middle East & Africa Facial Injectables Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 69: Middle East & Africa Facial Injectables Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 70: Middle East & Africa Facial Injectables Market Attractiveness Analysis, by Product Type, 2023-2031

    Figure 71: Middle East & Africa Facial Injectables Market Value Share Analysis, by Application, 2022 and 2031

    Figure 72: Middle East & Africa Facial Injectables Market Attractiveness Analysis, by Application, 2023-2031

    Figure 73: Middle East & Africa Facial Injectables Market Value Share Analysis, by End-user, 2017-2031

    Figure 74: Middle East & Africa Facial Injectables Market Attractiveness Analysis, by End-user, 2023-2031

Copyright © Transparency Market Research, Inc. All Rights reserved